Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: Systematic review and meta-analysis

European Journal of Endocrinology

Volumn 161, Issue 5, 2009, Pages 771-777

  De Rooij, A ^a   Vandenbroucke, J P ^a   Smit, J W A ^a   Stokkel, M P M ^a   Dekkers, O M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

CALCULATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DOSIMETRY; EMBASE; EUTHYROIDISM; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TOXIC GOITER; TREATMENT OUTCOME; ARTICLE; COMPARATIVE STUDY; RADIATION DOSE; RADIATION RESPONSE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 70449707282     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0286     Document Type: Review

References (27)

1. Cooper DS. Hyperthyroidism. Lancet 2003 362 459-468.
2. Laurberg P, Bulow Pedersen I, Pedersen KM & Vestergaard H. Low incidence rate of overt hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake. Thyroid 1999 9 33-38. (Pubitemid 29081148)
3. Volzke H, Schwahn C, Wallaschofski H & Dorr M. Review: the association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? Journal of Clinical Endocrinology and Metabolism 2007 92 2421-2429.
4. van Soestbergen MJ, van der Vijver JC & Graafland AD. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease. Journal of Endocrinological Investigation 1992 15 797-800.
5. Solomon BL, Evaul JE, Burman KD & Wartofsky L. Remission rates with antithyroid drug therapy: continuing influence of iodine intake? Annals of Internal Medicine 1987 107 510-512.
6. Solomon B, Glinoer D, Lagasse R & Wartofsky L. Current trends in the management of Graves' disease. Journal of Clinical Endocrinology and Metabolism 1990 70 1518-1524. (Pubitemid 20192897)
7. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y & Izumi M. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991 1 129-135.
8. Sisson JC, Avram AM, Rubello D & Gross MD. Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science? European Journal of Nuclear Medicine and Molecular Imaging 2007 34 1129-1130.
9. van Isselt JW, de Klerk JM & Lips CJ. Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science? European Journal of Nuclear Medicine and Molecular Imaging 2007 34 1883-1884.
10. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC & Cowden EA. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 2003 88 978-983. (Pubitemid 36337742)
11. Higgins JP, Thompson SG, Deeks JJ & Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 327 557-560.
12. Peters H, Fischer C, Bogner U, Reiners C & Schleusener H. Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study. European Journal of Clinical Investigation 1995 25 186-193.
13. Peters H, Fischer C, Bogner U, Reiners C & Schleusener H. Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 1997 7 247-251. (Pubitemid 27190591)
14. Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H & Salmi J. Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clinical Endocrinology 2004 61 641-648. (Pubitemid 39540368)
15. Franklyn JA, Daykin J, Drolc Z, Farmer M & Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clinical Endocrinology 1991 34 71-76.
16. Calegaro JU, De Freitas Gomes E, Bae SH, Ulyssea R & Casulari LA. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration. Panminerva Medica 2000 42 241-245.
17. Khanna CM, Magdum M, Ravishankar L, Dham DN & Chugh P. Evaluation of long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy (I 131). Journal of the Association of Physicians of India 1996 44 102-105. (Pubitemid 126470435)
18. 131I in the treatment of hyperthyroidism. Changgeng Yi Xue Za Zhi 1995 18 322-328.
19. Jarlov AE, Hegedus L, Kristensen LO, Nygaard B & Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clinical Endocrinology 1995 43 325-329.
20. Kok SW, Smit JW, de Craen AJ, Goslings BM, Eck-Smit BL & Romijn JA. Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study. Nuclear Medicine Communications 2000 21 1071-1078.
21. Ustun F, Yuksel M, Durmus-Altun G, Kaya M, Cermik TF, Sarikaya A & Berkarda S. The incidence of recurrence and hypothyroidism after radioiodine treatment in patients with hyper-thyroidismin Trakya, amild iodine deficiency area, during the period 1991-2003. Annals of Nuclear Medicine 2005 19 737-742.
22. Franklyn JA, Daykin J, Holder R & Sheppard MC. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Quarterly Journal of Medicine 1995 88 175-180.
23. Kaplan MM, Meier DA & Dworkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrinology and Metabolism Clinics of North America 1998 27 205-223.
24. Walter MA, Briel M, Christ-Crain M, Bonnema SJ, Connell J, Cooper DS, Bucher HC, Muller-Brand J & Muller B. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ 2007 334 514. (Pubitemid 46588147)
25. Jarlov AE, Hegedus L, Gjorup T & Hansen JE. Accuracy of the clinical assessment of thyroid size. Danish Medical Bulletin 1991 38 87-89.
26. van Isselt JW, de Klerk JM, Koppeschaar HP & Van Rijk PP. Iodine-131 uptake and turnover rate varyover short intervals inGraves' disease. Nuclear Medicine Communications 2000 21 609-616.
27. Romijn JA, Smit JW & Lamberts SW. Intrinsic imperfections of endocrine replacement therapy. European Journal of Endocrinology 2003 149 91-97.